Our Supporters

Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.

For more information visit Alexion.

Biogen are pioneers in neuroscience and, as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases including MS.

For more information visit Biogen.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound & Skin Care and Interventional Urology.

For more information visit Coloplast.

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Merck has more than 20 years of experience in MS care, and remains committed to finding solutions for patients’ significant unmet medical needs.
For more information visit Merck.

Novartis has a strong ongoing commitment to neuroscience and to bringing innovative treatments to patients suffering from neurological conditions where there is a high unmet need. Novartis are committed to supporting patients and physicians in multiple disease areas, including MS.

For more information visit Novartis.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Neuroscience is a major focus of research and development at Roche. The goal is to pursue groundbreaking science to develop new treatments that help improve the lives of people with chronic and potentially devastating diseases including multiple sclerosis.
For more information visit Roche.